• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, May 18, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

New Study Uncovers Shortcomings in Flu Treatment for High-Risk Adults

Bioengineer by Bioengineer
April 22, 2025
in Health
Reading Time: 5 mins read
0
ADVERTISEMENT
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

blank

INDIANAPOLIS – A multi-state study reveals that many high-risk adults diagnosed with influenza (flu) in emergency departments and urgent care centers are not receiving timely antiviral treatment. Researchers found that only slightly more than half of these patients received antiviral prescriptions, and of those, only 80 percent were filled. This gap in treatment could increase the risk of severe flu complications, particularly for older adults and those with underlying conditions.

The study analyzed prescribing and dispensing patterns of influenza antiviral medications across various demographic groups. Researchers found no significant disparities based on race, ethnicity or socio-economic vulnerability. However, high-risk adults aged 65 and older were less likely to receive timely prescriptions or receive dispensed medications compared to younger high-risk adults.

Patients considered high-risk included those with cardiovascular disease, renal disease, weakened immune systems, or individuals older than the age of 70. For these patients, timely antiviral treatment is critical, as influenza can lead to severe complications beyond the lungs, such as influenza encephalitis, a brain infection that causes inflammation and significant health issues.

“Although effective influenza vaccines are available, many adults remain unvaccinated, and breakthrough cases still occur. Fortunately, we have antivirals that can reduce complications,” said study co-author Shaun Grannis, M.D., M.S., vice president for data and analytics at Regenstrief Institute. “This can be a serious disease. Being treated quickly is not only important for individual health but also for public health. If someone has respiratory concerns, I strongly encourage them to contact their healthcare provider as soon as possible.”

Patients undergoing rapid flu tests in emergency departments and urgent care centers were more likely to be prescribed and dispensed antivirals. Rapid tests provide results in 5 to 10 minutes, allowing providers to confirm a diagnosis and prescribe antivirals within the recommended 48-hour treatment window.

Antiviral medications work by attacking flu viruses in the body, similar to how antibiotics fight bacterial infections. However, the effectiveness of antivirals declines if treatment begins more than 48 hours after symptoms appear. Many individuals seek care after this window has closed, making providers hesitant to prescribe antivirals. Additionally, some healthcare providers worry about drug interactions, particularly in high-risk patients who take multiple medications (polypharmacy).

The study analyzed electronic health record (EHR) data from 94 urgent care facilities and 142 emergency departments across five states—California, Minnesota, Oregon, Washington, and Wisconsin—through the Centers for Disease Control and Prevention (CDC) VISION Network.

Regenstrief Institute investigators have been pioneers in clinical decision support, and based on the study’s findings, Dr. Grannis suggests that decision support tools could help reduce barriers to timely treatment. “By integrating clinical decision support into electronic health records, we can guide providers to ensure high-risk patients receive antiviral treatment when it’s most effective,” he said.

The study, “Patterns in prescribing and dispensing of influenza antivirals among adults with influenza presenting to urgent care and emergency department settings, VISION Network, 2023–2024,” was funded by the CDC and is published in Clinical Infectious Diseases.

All authors and affiliations as listed in the paper:

Katherine Adams1, Shikha Garg1, Sara Y Tartof 2, Stephanie A Irving3, Malini B DeSilva4, Nicola P Klein5, Karthik Natarajan6,7, Kristin Dascomb8, Shaun J Grannis9,  Toan C Ong10, S Bianca Salas2, Lina S Sy2, Bruno Lewin2, Lei Qian2, Allison L Naleway3, Padma D Koppolu3, Charlene E McEvoy4, Omobosola Akinsete4, Inih Essien4, Bruce Fireman5, Ousseny Zerbo5, Karen B Jacobson5, Julius Timbol5, Varsha Neelam1, Emily L Reeves1, Monica Dickerson1, Caitlin Ray1, Ruth Link-Gelles11, Josephine Mak11, Sarah W Ball12, Michael O’Reilly13, Sonja J Olsen1, Mark W Tenforde1.

1 Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States.
2 Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, United States.
3 Kaiser Permanente Center for Health Research, Portland, Oregon, United States.
4 HealthPartners Institute, Minneapolis, Minnesota, United States.
5 Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California Division of Research, Oakland, California, United States.
6 Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, New York, United States.
7 Medical Informatics Services, New York-Presbyterian Hospital, New York, New York, United States.
8 Division of Infectious Diseases and Clinical Epidemiology, Intermountain Healthcare, Salt Lake City, Utah, United States.
9 Center for Biomedical Informatics, Regenstrief Institute, Indianapolis, Indiana, United States.
10 School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States.
11 Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States.
12 Westat, Rockville, Maryland, United States.
13 Rollins School of Public Health, Emory University, Atlanta, Georgia, United States.

About Shaun Grannis, M.D., M.S.

Dr. Shaun Grannis is vice president of data and analytics at Regenstrief Institute, the Regenstrief Chair in Medical Informatics, and a professor of family medicine at the Indiana University School of Medicine.

  

Journal

Clinical Infectious Diseases

DOI

10.1093/cid/ciaf178

Article Title

Patterns in prescribing and dispensing of influenza antivirals among adults with influenza presenting to urgent care and emergency department settings, VISION Network, 2023-2024

Article Publication Date

4-Apr-2025

Media Contact

Regenstrief Institute Public Relations

Regenstrief Institute

[email protected]

Journal
Clinical Infectious Diseases
Funder

Centers for Disease Control and Prevention

DOI
10.1093/cid/ciaf178

Journal

Clinical Infectious Diseases

DOI

10.1093/cid/ciaf178

Article Title

Patterns in prescribing and dispensing of influenza antivirals among adults with influenza presenting to urgent care and emergency department settings, VISION Network, 2023-2024

Article Publication Date

4-Apr-2025

Keywords

/Health and medicine

/Health and medicine/Clinical medicine/Medical treatments/Drug therapy/Medications/Antivirals

/Health and medicine/Human health/Public health

/Social sciences/Demography/Population studies

/Health and medicine/Diseases and disorders/Respiratory disorders

/Health and medicine/Medical specialties/Pathology/Disease control

/Social sciences/Demography/Age groups/Adults/Older adults

bu içeriği en az 2000 kelime olacak şekilde ve alt başlıklar ve madde içermiyecek şekilde ünlü bir science magazine için İngilizce olarak yeniden yaz. Teknik açıklamalar içersin ve viral olacak şekilde İngilizce yaz. Haber dışında başka bir şey içermesin. Haber içerisinde en az 12 paragraf ve her bir paragrafta da en az 50 kelime olsun. Cevapta sadece haber olsun. Ayrıca haberi yazdıktan sonra içerikten yararlanarak aşağıdaki başlıkların bilgisi var ise haberin altında doldur. Eğer yoksa bilgisi ilgili kısmı yazma.:
Subject of Research:
Article Title:
News Publication Date:
Web References:
References:
Image Credits:

Keywords

Tags: antiviral medication adherenceantiviral treatment high-risk adultsbreakthrough influenza casesdemographics influenza treatmentemergency department flu treatmentflu treatment shortcomingshigh-risk flu patientsinfluenza complications older adultsinfluenza vaccination ratesprescribing patterns influenza medicationstimely antiviral prescriptions studyurgent care flu management

Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Electroconvulsive Therapy Triggers Spreading Depolarization Wave

May 18, 2025
Waist-to-Height Ratio Emerges as a Key Predictor of Heart Failure Risk

Waist-to-Height Ratio Emerges as a Key Predictor of Heart Failure Risk

May 18, 2025

Inflammatory Signature Unites Severe Malaria Syndromes

May 18, 2025

Multi-Locus TMS System Advances Clinical Brain Therapy

May 18, 2025

POPULAR NEWS

  • blank

    Volatile-Rich Cap Found Above Yellowstone Magma

    665 shares
    Share 266 Tweet 166
  • Natural Supplement Shows Potential to Slow Biological Aging and Enhance Muscle Strength

    90 shares
    Share 36 Tweet 23
  • Analysis of Research Grant Terminations at the National Institutes of Health

    78 shares
    Share 31 Tweet 20
  • The Rise of Eukaryotic Cells: An Evolutionary Algorithm Spurs a Major Biological Transition

    68 shares
    Share 27 Tweet 17

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Revolutionary Wearable Sensor Offers New Insights into Monitoring OSA Treatment Efficacy

Scar Macrophages and Biliary Cells Drive Liver Fibrosis

Electroconvulsive Therapy Triggers Spreading Depolarization Wave

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.